The recent emergence of diverse immunotherapeutic agents has made it crucial to interpret a complex tumour microenvironment intermingled with tumour-infiltrating immune cells to predict the immunotherapeutic response rate. | Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma